跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要直接研究随机试验中的总体与亚组治疗效应检验及异质性。

反馈分类问题

Optimal Tests of Treatment Effects for the Overall Population and Two Subpopulations in Randomized Trials, Using Sparse Linear Programming

用稀疏线性规划优化随机试验总体与两个亚组的治疗效应检验

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Michael Rosenblum
Han Liu
En-Hsu Yen

用稀疏线性规划优化随机试验总体与两个亚组的治疗效应检验

研究问题
在两个预先定义的亚组可能具有不同治疗效应时,如何同时检验总体与亚组获益,并强控制家族第一类错误率?
方法与思路
作者将多重检验问题转化为大型稀疏线性规划,利用优化技术求解,并分别构造满足极小极大和贝叶斯准则的程序。
材料陈述的贡献
摘要称在给定最优性准则下可获得总体与亚组检验功效的最优权衡,并用两项 HIV 随机试验启发的例子说明。
阅读关注点
应核对原假设与错误率控制范围、功效目标及效应情景,以及线性规划转化、求解精度和最优性结论的适用条件。
阅读边界
仅据版本未注明的 OpenAlex 索引摘要;最优性取决于指定准则和约束,不能据此声称在所有试验中功效最高。

原文摘要

We propose new, optimal methods for analyzing randomized trials, when it is suspected that treatment effects may differ in two predefined subpopulations. Such subpopulations could be defined by a biomarker or risk factor measured at baseline. The goal is to simultaneously learn which subpopulations benefit from an experimental treatment, while providing strong control of the familywise Type I error rate. We formalize this as a multiple testing problem and show it is computationally infeasible to solve using existing techniques. Our solution involves a novel approach, in which we first transform the original multiple testing problem into a large, sparse linear program. We then solve this problem using advanced optimization techniques. This general method can solve a variety of multiple testing problems and decision theory problems related to optimal trial design, for which no solution was previously available. In particular, we construct new multiple testing procedures that satisfy minimax and Bayes optimality criteria. For a given optimality criterion, our new approach yields the optimal tradeoff between power to detect an effect in the overall population versus power to detect effects in subpopulations. We demonstrate our approach in examples motivated by two randomized trials of new treatments for HIV.

笔记与分组